SCHEMBL23099697

SCHEMBL23099697

CC(Cc1ccccc1)N(C)C(=O)c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.47
LIMK2 P53671 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA2C P18825 1/20 0.45
SLC6A2 P23975 1/20 0.45
HTR2A P28223 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KCNH2 Q12809 1/20 0.45
AGER Q15109 2/20 0.45
RAB9A P51151 1/20 0.45
MTNR1A P48039 1/20 0.45
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
ALDH1A1 P00352 1/20 0.43
BCHE P06276 2/20 0.43
ACHE P22303 2/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14008052 0.89 NPY5R (0.52) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL8615898 0.89 NPY5R (0.52) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14008053 0.89 NPY5R (0.52) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL23099904 0.82 ATM (0.44) LIMK2AGERRAB9AMTNR1APPARG
SCHEMBL11588617 0.77 ADRA2B (0.61) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL7636285 0.76 NPY5R (0.55) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL14008051 0.76 NPY5R (0.55) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL7636288 0.76 NPY5R (0.55) NPY5RADRA2BADRA2CSLC6A2HTR2A
SCHEMBL13034674 0.76 HDAC4 (0.49) RAB9AALDH1A1HPGDKMT2A
SCHEMBL5644792 0.75 LIMK2 (0.70) LIMK2AGERHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021050992-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. (US) 2021-03-18 WO disclosed